St. Paul's Hospital is a public hospital at 20th Street and Avenue P in the Pleasant Hill neighborhood of Saskatoon, Saskatchewan. St. Paul's works with the Saskatchewan Health Authority in an interdependent partnership.

During the past decade, St Paul's Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Paul's Hospital" #1 sponsor was "University of Saskatchewan" with 5 trials, followed by "Anesiva, Inc." with 1 trials sponsored, "Baxalta now part of Shire" with 1 trials sponsored, "Dr. Chandran Medical Prof Corp" with 1 trials sponsored and "Hamilton Health Sciences Corporation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Paul's Hospital" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Astellas Pharma Canada, Inc." with 1 trials as a collaborator, "Bard Ltd" with 1 trials as a collaborator, "Boston Medical Center" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "St Paul's Hospital" are "Kidney Transplantation" (2 trials), "Arterial Occlusive Diseases" (1 trials), "COVID-19" (1 trials), "Cardiovascular Disease" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "St Paul's Hospital" in a lesser frequency.

Most popular intervention types in "St Paul's Hospital" are "Drug" (8 trials), "Device" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody" (1 trials), "Aspirin" (1 trials), "CGT003 (E2F Duplex Decoy)" (1 trials), "Cellcept®" (1 trials) and "Clopidogrel 75" (1 trials). Other intervention names were less common.

The vast majority of trials in "St Paul's Hospital" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "St Paul's Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in St Paul's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in St Paul's Hospital, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".